Overview
Updated 14 Jul 2026
Jesús G. Berdeja, MD, is Director, Multiple Myeloma Research at Sarah Cannon Research Institute / Tennessee Oncology. The public record shows 531 publications with 18,892 citations (h-index 59), centered on Leukemia (AML/ALL/CML/CLL), Multiple Myeloma, MDS / MPN. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 30 companies.
- Most recent indexed publication: 2026 · Blood
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Caribou Biosciences, Inc.
InvestigatorPhase 1RecruitingNCT05722418 - A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Sponsor: GlaxoSmithKline
InvestigatorPhase 1/PHASE2RecruitingNCT05714839 - A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Sponsor: K36 Therapeutics, Inc.
InvestigatorPhase 1RecruitingNCT05651932
Industry payments
Updated 14 Jul 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
250 25th Ave N, Nashville, TN 37203
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Residency
Internal Medicine, University of California, San Francisco
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Fellowship
Medical Oncology and Hematology, Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Board Certified
Internal Medicine, Medical Oncology, and Hematology - American Board of Internal Medicine (ABIM)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗ - BS
Stanford University (undergraduate)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership rolesjournal and society appointments
- Member
International Myeloma Society (IMS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tnoncology.com ↗ - Member
International Myeloma Working Group (IMWG)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tnoncology.com ↗ - Member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tnoncology.com ↗
Secondary affiliationsappointments beyond the home institution
- Formerly
Stem Cell and Bone Marrow Transplant Program and Division of Hematology/Oncology, Loma Linda University
2008provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Sarah Cannon Center for Blood Cancers
Nashville, TN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Jesus-G-Berdeja-2152888066
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/BerdejaJesus
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/NashvilleHeme/status/1975565272770597305
- X / Twitter
x.com/theMMRF/status/1887501939962712126
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
- 5,579
- publications
- 233
- h-index
- 24
- trials
Jorge Cortes, MD
Augusta University
- 3,575
- publications
- 180
- h-index
- 67
- trials
Ayalew Tefferi, MD
Mayo Clinic
- 2,093
- publications
- 154
- h-index
- 7
- trials
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
- 639
- publications
- 131
- h-index
- 4
- trials